While recent evidence strongly suggests that the third complementarity determining regions (CDR3s) of T cell receptors (TCRs) directly contact antigenic peptides bound to major histocompatibility complex (MHC) molecules, the nature of other TCR contact(s) is less clear. Here we probe the extent to which different antigens can affect this interaction by comparing the responses of T cells bearing structurally related TCRs to cytochrome c peptides and staphylococcal enterotoxin A (SEA) presented by 13 mutant antigen-presenting cell (APC) lines. Each APC expresses a class II MHC molecule (I-E k) with a single substitution of an amino acid residue predicted to be located on the MHC c~ helices and to point "up" towards the TCR. We find that very limited changes (even a single amino acid) in either a CDR3 loop of the TCR or in a contact residue of the antigenic peptide can have a profound effect on relatively distant TCR/MHC interactions. The extent of these effects can be as great as that observed between T cells bearing entirely different TCRs and recognizing different peptides. We also find that superantigen presentation entails a distinct mode of TCR/MHC interaction compared with peptide presentation. These data suggest that TCR/MHC contacts can be made in a variety of ways between the same TCR and MHC, with the final configuration apparently dominated by the antigen. These observations suggest a molecular basis for recent reports in which either peptide analogues or superantigens trigger distinct pathways of T cell activation. l~ cent observations suggest that the TCR has a range of signaling capabilities. Limited variations in peptide ligands can induce qualitatively different T cell responses (1-3), and simple competition between peptides binding to MHC or between TCK and peptide/MHC complexes cannot adequately explain the results. In addition, it has been shown that T cell activation by a superantigen, in contrast to a peptide antigen, can occur without phosphoinositol turnover (4-6).
l~ cent observations suggest that the TCR has a range of signaling capabilities. Limited variations in peptide ligands can induce qualitatively different T cell responses (1) (2) (3) , and simple competition between peptides binding to MHC or between TCK and peptide/MHC complexes cannot adequately explain the results. In addition, it has been shown that T cell activation by a superantigen, in contrast to a peptide antigen, can occur without phosphoinositol turnover (4) (5) (6) .
One explanation for such differences in T cell signaling is that the effect of alteration of CDR3/peptide interaction is not only confined to the immediate vicinity of interaction but instead can have more widespread effects on the overall MHC/TCR interaction. Consequently, the configuration of TCR/Ag/MHC complexes formed with structurally similar peptide antigens or with a superantigen could be different enough to variably influence the association of the engaged TCR with other cell surface molecules (CD3, CD4, or CD8, etc.), thereby affecting the outcome of signaling.
To begin to address this question, we have developed an experimental system to evaluate the extent to which antigenic ligands affect the overall TCR/MHC interaction. This is achieved by analyzing responses of T cells expressing structurally related TCKs to either peptide analogues or a bacterial superantigen, Staphylococcal enterotoxin A (SEA), 1 presented by mutant I-E k molecules that contain single amino acid substitutions of residues predicted to point "up" from the ol-helical regions of the MHC (7) . The T cells are in most cases hybridomas derived from transgenic mice (8) expressing either the TCK c~ or fl chain of the T cell clone 5C.C7 (9) . They react to moth cytochrome c (MCC 88-103) peptide or its analogues bound to the class II MHC molecule, I-E k. A subset of these hybridomas are able to recognize both wild-type MCC peptide (MCC [99K] ) and the 99E analogue containing a glu --~ lys substitution at residue 99, a position predicted to point up towards the TCK (8, 10, 11) . Others recognize the same cytochrome c peptide with TCR sequence differences limited to a single TCR oL or chain CDR3 region. As shown previously (8) , the CDR3 region of the TCR directly contacts the antigenic peptide bound to MHC molecules. Analysis of both sets of hybridomas allows us to evaluate the effect of small defined changes in either TCR CDR3 or peptide on the overall MHC/TCR interaction. For comparison, we analyzed other cytochrome c-reactive hybridomas that express TCRs differing with respect to Vc~ allele or V~/gene segment, as well as T cells with unrelated TCRs that recognize peptides other than MCC.
In this report, we show that T cells with TCRs differing only in a single CDR3 region of either the oe or ~ chain respond differently to peptide presented by the mutant APCs. T cell hybridomas that are crossreactive to two related peptides also show strikingly different sensitivities to some I-E~ k and bEa k mutants, depending on which peptide is being recognized. Surprisingly, the extent of TCR/peptide/MHC changes brought about by small changes in an apparent CDR3/peptide contact can be as great as those observed between T cells expressing unrelated TCRs. Both these results suggest that the TCR/peptide interaction dominates the final configuration of the ternary complex. In the case of the same T cell responding to superantigen/I-E k vs. a peptide/I-E k complex, the sensitivities to the I-E k mutations are also very different. Taken together the data suggest that TCR/MHC interactions are extremely "fluid" and can be influenced profoundly by small changes in the antigen. As this may influence signaling through the TCR, it has important implications for our understanding of thymic differentiation and peripheral T cell tolerance.
Materials and Methods
Mutant APC Lines. Full-length I-E k o~ and ~ chain cDNAs (12) cloned in the Bluescript SK-plasmid (Stratagene, San Diego, CA) (13) were subjected to site-directed mutagenesis (14) . Oligonucleotides for mutagenesis were synthesized with a DNA synthesizer (394; Applied Biosystems, Inc., Foster City, CA). Mutant plasmids were identified by DNA sequencing (Sequenase sequencing kit) (United States Biologics, Indianapolis, IN). The eukaryotic expression vectors pBJ1-Neo and PBJ1 were used to express the cr and/3 chain, respectively (15) . The cr heterodimer was reconstituted by expression of a mutant c~ or/3 chain with the complementary wild-type chain by cotransfection in Chinese hamster ovary (CHO) cells as described by Wettstein et al. (13) . G418 (Gibco Laboratories, Grand Island, NY) -resistant cells were pooled and sorted after staining with anti I-E mAb 17.3.3 (16) . Positive cells were cloned by cell sorting. The levels of surface expression of each mutant and wild-type I-E k are within a twofold range. T Cell Hybridomas. The T cell hybridoma 3I was derived from an A/J mouse immunized with X repressor ci P 1-102 (17) . Y01.6 is from CE/j (Hb~') mice immunized with CBA/J (HbB d) Hb (18) , and 2B4 is from a B10.A mouse immunized with pigeon cytochrome c (19) . Hybridomas 104, 226, 115, K5, K17, K20, E6, E20, E22, E26, and E28 were obtained by immunizing mice expressing the transgene for either the TCR c~ or ~ chain of the cytochrome c-reactive T cell clone 5C.C7 (8) . The primary TCR structure of these hybridomas is presented in Table 1 .
Antigen Presentation Assays. Antigen presentation assays were carried out with 2 x 104 APCs, 5 x 104 responder cells (T cell hybridomas), and various concentrations of SEA or peptide in a final volume of 0.2 ml, and incubated for 18 h at 37~
The amount of Ib2 produced at each antigen concentration was assayed in duplicate using the IL-2-dependent HT-2 cell line (20) . A complete dose-response titration was performed independently at least twice and in many instances more than three times to verify reproducibility. Presentation efficiency was estimated as follows: the antigen concentration required to elicit half-maximal Ib2 production by the wild-type APC was defined as C1/zw,, and that of a mutant APC to elicit the same amount of Ib2 was defined as Cl/~ut. The effect of the mutant I-E k lines on presentation was evaluated by taking the ratio of C1/2mu, to C~/zw,. Values reported in Fig. 5 represent an average from two to three independent experiments.
Binding Assays. FACS | analysis (Becton Dickinson & Co., Mountain View, CA) of peptide and SEA binding to I-E k CHO cells was carried out with biotinylated MCC 99K and 99E peptides and hemoglobin peptide using a modification of the protocol of Busch et al. (21) , and biotinylated SEA using a modification of the protocol of Herman et al. (22) . Binding was carried out at 37~ for 4 h in PBS, 5% FCS, 0.1% sodium azide followed by incubation with allophycocyanin (Biomeda, Foster City, CA) or PE (Southern Biotechnology Associates, Birmingham, AL) -conjugated streptavidin. To normalize peptide binding with cell surface I-E expression, cells were simultaneously stained with anti-I-E antibody 17.3.3 (16) followed by FITC-conjugated goat anti-mouse IgG (Sigma Chemical Co., St. Louis, MO).
Results

Expression of Mutant IF. k on CHO Cells. A series of six
I-E~ k and seven I-E~' mutants were made by site-directed mutagenesis (14) and transfected into CHO ceils. Each mutant chain expresses a single substitution of an amino acid residue that is predicted to lie on "top" of the c~ helices that form the MHC/peptide binding groove (7) . The one exception is the mutation at position 72 of the MHC eel helix. The side chain of o~72 is predicted to point upwards and thus is potentially available to contact the TCR. The amino acid substitutions were selected to disrupt interactions between the TCR and MHC maximally while maintaining the native tertiary structure of the I-E k molecule. To preserve the structure, the substituted amino acids are similar in hydropho- vcy, c~v-J junction, J~, v/3,/3V-D-J junction, and J/3 sequences are listed or indicated for TCKs of 2B4 (19), YO1.6 (Paul Allen, personal communication), and 3I (44) . 115, 226, and 104 express the TCR/3 chain of the 5C.C7 T cell line. E6, E28, E20, E22, E26, K5, K17, and K20 express the 5C.C7 TCR c= chain (8) .
bicity to the wild-type amino acid. To disrupt contacts with the TCIL, the mutations either reverse charges (c=79,/359, /369, and/384, Glu to Lys) or increase the size of the side chain to promote steric hindrance (o~65, o~68, ol72, and/373, Ala to Val;/381, His to Tyr; c=57, Set to Asn; and/377, Thr to Gin) ( Fig. 1 ). For c~61,/364, the Gln residue is changed to Arg; this not only increases the side chain volume but also introduces a basic guanido group. Cell surface expression of I-E k was verified by staining with anti-I-E mAbs, including 14.4.4 (16) has reduced 40D staining (more than threefold) (data not shown). Because these two clones stain normally with the other anti-I-E antibodies, it is likely that these two mutations, o161 and/369, lie within or near the determinant of epitopes for 14.4.4 and 40D, respectively. The fact that all the mutants retain the capacity to be recognized by five or more antibodies indicates that their secondary and tertiary structure is not grossly distorted.
Antigen Binding of Mutant I-E k on CHO Cells.
Since the transfectants were used as APCs, we assessed the ability of each line to bind peptides and the superantigen, SEA. All mutant and wild-type I-Ek-expressing cells bind biotinylated MCC(99K), MCC(99E), and biotinylated hemoglobin peptides to a similar extent (within a threefold range) (Fig. 2) . These results are consistent with the prediction that the mutated amino acid residues point away from the MHC peptide groove (7) and therefore do not interfere with peptide binding. MCC(99K) and MCC(99E) bind to each mutant similarly, confirming prior observations that position 99 of the cytochrome c peptide does not affect MHC binding and thus is consistent with evidence that position 99 directly contacts the TCR (8, 26) . Biotinylated SEA binds to the mutant I-Ek-expressing CHO cells to a similar extent as wild-type I-Ek-expressing cells, with the exception of/369 and/381 (Fig. 3) . With/381, there is no detectable SEA binding, consistent with mutagenesis studies on HLA-DR, the human equivalent of I-E k (27, 28) ./369 showed decreased binding with fourfold less staining at the highest concentration of SEA used (40 gg/ml). I 10 100 Biotinylated SEA mg/ml Responses ofT Cells with TCRs Differing Only in the CDR3 Region of theft Chain. Three hybridomas, E6, E20, and E28, specific for the MCC peptide variant MCC(102E) (Thr -'* Glu substitution at position 102) were analyzed. They express the transgenic 5C.C7 TCR o~ chain (Vodl.1) together with VB1. E6 and E28 use JB1.2, whereas E20 expresses JBI.1. Each hybridoma has a distinct TCR B junctional sequence (Table 1) . Ahhough these hybridomas respond to some mutant APCs similarly, they respond differently to others. Most strikingly, E28 alone shows an enhanced response with the /364 mutant, whereas recognition by the other two T cell hybrids is dramatically impaired. Mutations at c~61, c~68, c~72, and ~81 also variably affect these three T cells (Figs. 4 C  and 5 ). These results indicate that amino acid residues within the B chain CDR3 can significantly affect the interaction of the TCR with the MHC molecule as well.
Responses of Crossreactive Hybridomas to Different Antigens,
Responses ofT Cells with TCRs Differing Only in the CDR3
Another set of 102E-reactive T cell hybridomas, E22 and E26, were analyzed. Similar to E6, E20, and E28, they are also derived from 5C.C7 o~ chain transgenic mice and express the 5C.C7 TCR o~ chain. Both express V~6 but with different junctional regions ( Table 1 ). The responses of these two hybridomas to the panel of APCs show very similar patterns (Fig. 5) : Mutations at B64,/369, and/377 reduce the ability of the APC to elicit responses from both hybridomas, whereas mutations at other positions of I-E k molecule have no measurable effect.
Because the response patterns of E6, E20, and E28 to the mutant I-Ek's are quite distinct while those of E22 and E26 are quite similar, an additional set of T cell hybridomas with TCRs differing only in the TCR fl CDR3 region were analyzed. Hybridomas KS, K17, and K20 are also derived from 5C.C7 TCR ol chain transgenic mice but use Vf114 and recognize the MCC(102K) peptide (Thr --~ Lys substitution at position 102) ( Table 1 ). K5 and K17 have nearly identical TCR sequences with the exception of a single amino acid located in the CDR3 region. In K17, this amino acid (Glu) is predicted to contact the Lys at position 102 of the peptide (8) . At the corresponding position in K5, a serine residue is present. K20 also has a glutamic acid within the CDR3 but expresses Jf12.4 instead of Jill.l, as is the case with K5 and K17. Surprisingly, although the TCR structure of K5 and K17 differs by a single amino acid, their responses to two mutants, fl59 and fl64, are strikingly different, fl59 and fl64 exert no effect on the presentation of 102K to K17 but severely (fl64) and moderately (fl59) inhibit the presentation to K5. In contrast to both K5 and K17, ol68 and c~72 show enhanced presentation with K20 while fl81 and fl84 have no effect on presentation to K20 (Fig. 5) .
Responses of T Cells with TCRs Differing Only in the Vcr Gene Segment (Vc~11.1 vs. Vcr11.2): Hybridomas 104 and 226.
The difference between the TCRs expressed by hybridomas 104 and 226 is limited to five amino acids in the Vc~ gene. Three nonconservative amino acid changes are located in the D -~ E loop (close to CDR1). The other two differences are adjacent to CDR1 on the TCR C strand (29) . Comparing 104 and 226 enables us to assess the effects of limited variation in the Vc~ gene segment on the interaction of the TCR with the MHC/peptide complex.
As discussed previously, three of the I-E k fl mutants show differing effects in presenting 99K peptide to these two hybridomas. Mutations at fl64 and fl69 abolish presentation to hybridoma 104, but have small or no effect on the responses of 226. The response of 226, but not 104, is enhanced by the fl81 mutant.
I-E k mutants also affect the presentation of 99E peptide differently, fl73 and fl81 impair presentation to both hybridomas but to varying degrees. 226, but not 104, shows enhanced responses to the oe65 and o~68 mutations. (Figs. 4, A and B, and 5) .
Presentation of SEA to T Cells Expressing
It has been shown that superantigen recognition does not depend on MHC class II amino acid residues located inside 719
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the peptide binding groove (30) . These results expand on their finding and establish that MHC/TCR interactions are also dissimilar in the T cell recognition of a superantigen/MHC complex compared with a peptide/MHC complex.
Presentation of Peptide Antigens to T Cells with Unrelated TCRs.
The activation of three hybridomas expressing structurally unrelated TCRs by these panels of mutant APCs was also compared. The three are 2B4 (19) , which recognizes moth or pigeon cytochrome c and expresses V~11.2 and Va3; Y01.6 (18) , which recognizes a hemoglobin flami, peptide and expresses Va15; and 3I, which recognizes a X repressor peptide and expresses V~2 with Val (31) . Results are summarized in Fig. 5 . Some mutants have no effect on peptide presentation while others abolish stimulation entirely. There is considerable variation among some of the mutants in their capacities to stimulate these T cells. This finding is consistent with prior reports (30, 32) probing TCR/MHC interaction with T ceils of structurally unrelated or uncharacterized TCRs. It is interesting that the extent of these differences is no greater than that found between hybridomas with much more similar TCRs and antigens discussed previously.
Discussion
In this report, we find that single amino acid substitutions of the antigenic peptide, or changes in a single CDR3 region, can dramatically change the overall TCR/MHC interaction. It is also clear that superantigen/MHC complexes have a completely different mode of interaction with TCR compared with peptide/MHC ligands. These results suggest contacts between the TCR and MHC are extremely "fluid" in that they can be made in a variety of ways with the final (Fig. 5) .
It is striking that the extent of the effects on MHC/TCR interaction accompanying a changed CDR3/peptide interaction can be as great as those observed with T calls using TCRs with different Vfl gene segments or with unrelated TCRs recognizing different peptide antigens. It was unexpected that T ceils that express different Vc~ gene suballeles (104 and 226) would also show similar degrees of variation in their sensitivity to the mutant MHCs. This finding is especially remarkable as none of the sequence differences between Vo~11.1 and Vot11.2 are nonconservative amino acid changes located in the CDR1 or CDR2 loops, which putatively contact the MHC ol helices (33) (34) (35) (36) . It should be noted, however, that the five amino acids that distinguish Vc~11.1 from Vc~11.2 are located on the D -* E loop and the C strand. Our recent mutagenesis study of the 2B4 TCR has demonstrated that single nonconservative amino acid substitutions in the C strand of the o~ chain can dramatically affect recognition of MCC (Rock et al., manuscript in preparation). Moreover, a computer modeling study suggests that substitutions in the D -* E loop could influence the conformation of the adjacent TCR ol chain CDR1.
It is unlikely that the results cited in point (a) above are due to an interruption of direct contacts between the TCR CDR3 loops and the MHC ct helices. Given the predicted distance between these mutated amino acid residues on the I-E k molecule (~o25 A between the ot carbon of residues B59 and/~81), it is inconceivable that they could be simultaneously contacted by the altered amino acids of a single CDR3 loop.
It is also unlikely that our observations merely reflect the relative sensitivity of these T cells to Ag/MHC stimulation. Although there is a correlation between C1/2wt and sensitivity to the mutant APCs for SEA recognition, no consistent correlation can be discerned in peptide recognition. For example, while the greater C1/2wt of 99E for 104 to 226 correlates with more pronounced effects by the mutant I-Ek's on 104 than 226, no such correlation can be found for 226, 104, and 115 responding to the 99K peptide; K5, K17, and K20 responding to 102K peptide; or E6, E20, and E28 responding to 102E peptide. Last, it is unlikely that our observation derived from uncontrolled variables in the experiments. We have tested two independent clones derived from the same fusion that have the same TCR and found them to yield identical patterns with the panel of I-E k mutants (data not shown).
Our results suggest there is no a priori mode of interaction between the TCR and the MHC, but rather an "optimization" of the contacts is obtained for each ternary complex. Superantigen interaction with TCR and MHC as compared with peptide antigen may represent the most extreme case of such optimization. In this context it is interesting to note the recent report that a CDR3 loop of an Ig heavy chain can change markedly in both main and side chain conformations to enable high affinity antigen recognition (37) . In the case of TCR, both ct and fl chain CDR3s are as long as Ig heavy chain CDR3s and several residues longer than light chain CDR3s. The enhanced conformational flexibility of TCR CDR3 loops relative to those of antibodies could lead to significant secondary effects on the structure of juxtaposed CDR1 and CDR2 loops. In addition, the binding of TCR to peptide/MHC complexes could also involve water acting as an "adaptor" molecule, as has been proposed for antigen/antibody interactions (38) . By filling gaps between loops on the TCR and between the TCR and antigen/MHC complex, water molecules could therefore be involved directly in the interaction of TCR and antigen/MHC and stabilization of different conformations of the TCR/Ag/MHC complex. Thus, broad-scale induced fit of ligand-binding surfaces on TCR ct and B chains might be a general component of recognition by the TCR.
A consequence of this broad-scale "induced fit" model would be that structurally related ternary complexes could differ in conformation of TCR and/or Ag/MHC. Along this line, an antibody-induced conformational change of TCR has been postulated by Rojo and Janeway (39) to explain the differences in T cell activation potency between different anti-TCR antibodies. Small conformational changes in an MHC class I molecule have also been found to be induced by binding different peptides (40) . Structurally related ternary complexes may also differ in the "angle of approach" between the TCR and the Ag/MHC complex and/or a different intermolecular orientation, as is suggested by the observation that some T cells are sensitive to mutations located in the E~ chain whereas others are not.
As T cell signal transduction through the TCR requires the association of TCR, CD3 molecules (% ~, e, ~', ~/), and either CD4 or CD8, as well as other cell surface accessory molecules (41, 42) , one could envision that differences in the configuration of TCR/Ag/MHC may have qualitative and/or quantitative effects on the subsequent association of the engaged TCR with other T cell surface molecules. This may be analogous to growth factor receptors, where dimerization and conformational changes induced by ligand binding appear to be important in signaling (43) .
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